Article
Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas.
Cancer research - 15 Jul 1993
Garcia de Palazzo I E, Adams G P, Sundareshan P, Wong A J, Testa J R, Bigner D D, Weiner L M
Abstract excerpt
The development of novel immunotherapy strategies for non-small cell lung cancer (NSCLC) will be facilitated by the identification of tumor-specific targets. Although the epidermal growth factor receptor (EGFR) is overexpressed in many cases of NSCLC, its wide distribution in normal tissue may limit its suitability as an immunotherapeutic target. However, mutations within the EGFR that are unique to malignancies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
